Emergent Biosolutions Completes Sale of Baltimore-Camden Manufacturing Site; Shares Fall-March 2024-www.financetom.com

Emergent Biosolutions Completes Sale of Baltimore-Camden Manufacturing Site; Shares Fall

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Emergent Biosolutions Completes Sale of Baltimore-Camden Manufacturing Site; Shares Fall

Aug 20, 2024 9:39 AM

12:05 PM EDT, 08/20/2024 (MT Newswires) -- Emergent Biosolutions ( EBS ) said Tuesday that it has completed the sale of its drug manufacturing facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals for about $30 million.

"This milestone is a significant step forward in our multi-year plan to stabilize, turnaround, and transform Emergent," said CEO Joe Papa. "We continue to execute our multi-year plan to improve overall profitability and raise capital to reduce our debt."

Shares of Emergent Biosolutions ( EBS ) were down more than 14% in recent trading.

Price: 10.38, Change: -1.73, Percent Change: -14.26

Previous page： SJW Group Q2 Adjusted Earnings, Revenue Increase Next page： Celestica Q2 Adjusted Earnings, Revenue Increase; 2024 Guidance Raised

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

SJW Group Q2 Adjusted Earnings, Revenue Increase

Jul 25, 2024

04:18 AM EDT, 07/25/2024 (MT Newswires) -- SJW Group ( SJW ) reported Q2 adjusted earnings late Wednesday of $0.66 per diluted share, up from $0.58 a year earlier. Two analysts polled by Capital IQ expected $0.58. Operating revenue for the quarter ended June 30 was $176.2 million, up from $156.9 million a year earlier. One analyst surveyed by Capital...

Celestica Q2 Adjusted Earnings, Revenue Increase; 2024 Guidance Raised

Jul 25, 2024

04:27 AM EDT, 07/25/2024 (MT Newswires) -- Celestica ( CLS ) reported Q2 adjusted earnings late Wednesday of $0.91 per diluted share, up from $0.55 a year earlier. Analysts polled by Capital IQ expected $0.82. Revenue for the quarter ended June 30 was $2.39 billion, compared with $1.94 billion a year earlier. Analysts surveyed by Capital IQ expected $2.25 billion....

Live Oak Bancshares Q2 Earnings, Revenue Increase

Jul 25, 2024

04:31 AM EDT, 07/25/2024 (MT Newswires) -- Live Oak Bancshares ( LOB ) reported Q2 earnings late Wednesday of $0.59 per diluted share, up from $0.39 a year earlier. Four analysts polled by Capital IQ expected $0.46. Revenue for the quarter ended June 30 was $125.5 million, up from $108.5 million a year earlier. Four analysts surveyed by Capital IQ...

Empire State Realty Trust Q2 Earnings, Revenue Decline

Jul 25, 2024

04:24 AM EDT, 07/25/2024 (MT Newswires) -- Empire State Realty Trust ( ESRT ) reported Q2 earnings late Wednesday of $0.10 per diluted share, down from $0.14 a year earlier. An analyst polled by Capital IQ expected $0.04. Revenue for the quarter ended June 30 was $189.5 million, compared with $190.5 million a year earlier. An analyst surveyed by Capital...